SEC begins formal investigation of Newton biotech company The Securities and Exchange Commission has upgraded its investigation of Pro-Pharmaceuticals Inc. of Newton from an informal inquiry to a formal probe, according to the firm's most recent quarterly report to investors. The federal securities watchdog is looking at whether false or misleading statements were made about Pro-Pharmaceuticals, possibly by the company itself.